Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Trobridge, Grant D ^a,b   Wu, Robert A ^a   Beard, Brian C ^a   Chiu, Sum Ying ^a   Muñoz, Nina M ^a   von Laer, Dorothee ^c   Rossi, John J ^d   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; LENTIVIRUS VECTOR; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CELL PROTECTION; CELL SELECTION; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; LYMPHOCYTE; MACACA; MYELOABLATIVE CONDITIONING; NONHUMAN; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; WHOLE BODY RADIATION; ANIMAL; CELL LINE; CYTOLOGY; HELA CELL; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; METABOLISM; METHODOLOGY; MUTATION; PLASMID;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA NEMESTRINA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANIMALS; CELL LINE; GENE THERAPY; HELA CELLS; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HUMANS; LYMPHOCYTES; LYMPHOMA; MACACA NEMESTRINA; MUTATION; PLASMIDS; TRANSGENES;

EID: 70449427961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007693     Document Type: Article

References (56)

1. (2008) 07 AIDS Epidemic Update. Geneva, Switzerland: UNAIDS and WHO Press.
2. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, et al. (2002) Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel (Review) [erratum appears in JAMA. 2003 Jan-Feb;11(1):32]. JAMA 288: 222-235.
3. Carr A (2003) Toxicity of antiretroviral therapy and implications for drug development (Review). Nature Reviews Drug Discovery 2: 624-634.
4. Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, et al. (2003) Medicine. The need for a global HIV vaccine enterprise. Science 300: 2036-2039.
5. (2007) Cold shower for AIDS vaccines (Editorial). Nat Med 13: 1389-1390.
6. Buchschacher GL Jr, Wong-Staal F (2001) Approaches to gene therapy for human immunodeficiency virus infection (Review). Hum Gene Ther 12: 1013-1019.
7. Strayer DS, Branco F, Landre J, BouHamdan M, Shaheen F, et al. (2002) Combination genetic therapy to inhibit HIV-1. Molecular Therapy 5: 33-41.
8. Rossi JJ, June CH, Kohn DB (2007) Genetic therapies against HIV (Review). Nat Biotechnol 25: 1444-1454.
9. Dropulic B, June CH (2006) Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome (Review). Hum Gene Ther 17: 577-588.
10. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, et al. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360: 692-698.
11. Bauer G, Selander D, Engel B, Carbonaro D, Csik S, et al. (2000) Gene therapy for pediatric AIDS (Review). Ann NY Acad Sci 918: 318-329.
12. Amado RG, Mitsuyasu RT, Rosenblatt JD, Ngok FK, Bakker A, et al. (2004) Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther 15: 251-262.
13. Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, et al. (2009) Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med 15: 285-292.
14. Trobridge GD, Beard BC, Gooch C, Wohlfahrt M, Olsen P, et al. (2008) Efficient transduction of pigtailed macaque hemtopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111: 5537-5543.
15. Brennan G, Kozyrev Y, Kodama T, Hu S-L (2007) Novel TRIM5 isoforms expressed by Macaca nemestrina. J Virol 81: 12210-12217.
16. Joag SV (2000) Primate models of AIDS (Review). Microbes & Infection 2: 223-229.
17. Davis BM, Roth JC, Liu L, Xu-Welliver M, Pegg AE, et al. (1999) Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy. Hum Gene Ther 10: 2769-2778.
18. Neff T, Beard BC, Peterson LJ, Anandakumar P, Thompson J, et al. (2005) Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 105: 997-1002.
19. Neff T, Horn PA, Peterson LJ, Thomasson BM, Thompson J, et al. (2003) Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J Clin Invest 112: 1581-1588.
20. Trobridge G, Beard BC, Kiem H-P (2005) Hematopoietic stem cell transduction and amplification in large animal models. Hum Gene Ther 16: 1355-1366.
21. Crone TM, Goodtzova K, Edara S, Pegg AE (1994) Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine. Cancer Res 54: 6221-6227.
22. Xu-Welliver M, Kanugula S, Pegg AE (1998) Isolation of human O6-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by O6-benzylguanine. Cancer Res 58: 1936-1945.
23. Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, et al. (2004) Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J Virol 78: 568-575.
24. Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, et al. (2003) Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Molecular Therapy 8: 196-206.
25. Horn PA, Keyser KA, Peterson LJ, Neff T, Thomasson BM, et al. (2004) Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103: 3710-3716.
26. Salter RD, Howell DN, Cresswell P (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
27. Howell DN, Andreotti PE, Dawson JR, Cresswell P (1985) Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol 134: 971-976.
28. Kimpton J, Emerman M (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 66: 2232-2239.
29. Chackerian B, Long EM, Luciw PA, Overbaugh J (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 71: 3932-3939.
30. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517-7521.
31. Kreklau EL, Liu N, Li Z, Cornetta K, Erickson LC (2001) Comparison of singleversus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity. J Pharmacol Exp Ther 297: 524-530.
32. Jung CW, Beard BC, Morris JC, Neff T, Beebe K, et al. (2007) Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates. Exp Hematol 35: 1132-1139.
33. Gerull S, Beard BC, Peterson LJ, Neff T, Kiem H-P (2007) In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs. Hum Gene Ther 18: 451-456.
34. Kiem H-P, Allen J, Trobridge G, Olson E, Keyser K, et al. (2007) Foamy virus-mediated gene transfer to canine repopulating cells. Blood 109: 65-70.
35. Hermann FG, Martinius H, Egelhofer M, Giroglou T, Tonn T, et al. (2009) Protein scaffold and expression level determine antiviral activity of membraneanchored antivital peptides. Hum Gene Ther 20: 325-336.
36. Ngoi SM, Chien AC, Lee CG (2004) Exploiting internal ribosome entry sites in gene therapy vector design (Review). Current Gene Therapy 4: 15-31.
37. Li M, Rossi JJ (2005) Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells. Methods in Molecular Biology 309: 261-272.
38. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A thirdgeneration lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
39. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283: 682-686.
40. Mautino MR, Morgan RA (2000) Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA. Hum Gene Ther 11: 2025-2037.
41. Bahner I, Sumiyoshi T, Kagoda M, Swartout R, Peterson D, et al. (2007) Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Molecular Therapy 15: 76-85.
42. Kiem H-P, Wu RA, Sun G, von Laer D, Rossi JJ, et al. (2009) Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Therapy;Advance online publication, 10 September 2009; doi:10.1038/gt.2009.118.
43. Brandt S, Blissenbach M, Grewe B, Konietzny R, Grunwald T, et al. (2007) Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathogens 3: e54.
44. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R (2006) HIV-1 infection and CD4 T cell depletion in the humanized Rag22-/-gamma c-/ -(RAG-hu) mouse model. Retrovirology 3: 76.
45. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, et al. (2007) Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/-mice. J Virol 81: 2700-2712.
46. Levy JA (1996) The value of primate models for studying human immunodeficiency virus pathogenesis (Review). Journal of Medical Primatology 25: 163-174.
47. Nathanson N, Hirsch VM, Mathieson BJ (1999) The role of nonhuman primates in the development of an AIDS vaccine (Review). AIDS 13 (Suppl.A): S113-S120.
48. Warren J (2002) Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates. Journal of Medical Primatology 31: 237-256.
49. Naldini L (1998) Lentiviruses as gene transfer agents for delivery to non-dividing cells. Current Opinion in Biotechnology 9: 457-463.
50. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, et al. (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24: 687-696.
51. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
52. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
53. An DS, Qin FX, Auyeung VC, Mao SH, Kung SK, et al. (2006) Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Molecular Therapy 14: 494-504.
54. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
55. Aagaard L, Zhang J, von Eije KJ, Li H, Saetrom P, et al. (2008) Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther 15: 1566.
56. Hanawa H, Hematti P, Keyvanfar K, Metzger ME, Krouse A, et al. (2004) Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103: 4062-4069.